ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $442,684 | -27.7% | 40,244 | -2.7% | 0.00% | -20.0% |
| Q4 2022 | $611,876 | -2.4% | 41,343 | +26.0% | 0.01% | -16.7% |
| Q3 2022 | $627,000 | -3.5% | 32,813 | +7.6% | 0.01% | 0.0% |
| Q2 2022 | $650,000 | -34.8% | 30,499 | -41.1% | 0.01% | -45.5% |
| Q1 2022 | $997,000 | -17.4% | 51,783 | -11.0% | 0.01% | -21.4% |
| Q4 2021 | $1,207,000 | -17.9% | 58,203 | -5.5% | 0.01% | 0.0% |
| Q3 2021 | $1,471,000 | -18.5% | 61,578 | -6.9% | 0.01% | -12.5% |
| Q2 2021 | $1,805,000 | -31.1% | 66,124 | -27.0% | 0.02% | -38.5% |
| Q1 2021 | $2,621,000 | +35.0% | 90,614 | +31.3% | 0.03% | +18.2% |
| Q4 2020 | $1,942,000 | +36.1% | 69,025 | +41.8% | 0.02% | +4.8% |
| Q3 2020 | $1,427,000 | -9.3% | 48,694 | -6.5% | 0.02% | 0.0% |
| Q2 2020 | $1,574,000 | – | 52,053 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
| Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
| Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
| Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
| RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
| Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
| CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
| FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
| Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |